Coordinate expansion of murine hematopoietic and mesenchymal stem cell compartments by SHIPi

Stem Cells

Volumn 33, Issue 3, 2015, Pages 848-858

  Brooks, R ^a   Iyer, S ^a   Akada, H ^a   Neelam, S ^a   Russo, C M ^b   Chisholm, J D ^b   Kerr, W G ^a,b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SYRACUSE UNIVERSITY   (United States)

Author keywords

3AC; Bone marrow transplantation; G CSF; Hematopoietic stem cells; Mesenchymal stem cells; SHIP1

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ENZYME INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; SH2 DOMAIN CONTAINING INOSITOL 5 PHOSPHATASE 1 INHIBITOR; UNCLASSIFIED DRUG; INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE; PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DEPRESSION; CELL CYCLE G2 PHASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; S PHASE CELL CYCLE CHECKPOINT; STEM CELL EXPANSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

MURINAE; MUS;

ANIMALS; CELL MOVEMENT; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PHOSPHORIC MONOESTER HYDROLASES;

EID: 84923246428     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1902     Document Type: Article

References (54)

1. Perry JM, He XC, Sugimura R, et al. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Genes Dev 2011; 25: 1928-1942.
2. Polak R, Buitenhuis M,. The PI3K/PKB signaling module as key regulator of hematopoiesis: Implications for therapeutic strategies in leukemia. Blood 2012; 119: 911-923.
3. Zhang J, Grindley JC, Yin T, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006; 441: 518-522.
4. Kerr WG,. A role for SHIP in stem cell biology and transplantation. Curr Stem Cell Res Ther 2008; 3: 99-106.
5. Desponts C, Hazen AL, Paraiso KH, et al. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood 2006; 107: 4338-4345.
6. Hazen AL, Smith MJ, Desponts C, et al. SHIP is required for a functional hematopoietic stem cell niche. Blood 2009; 113: 2924-2933.
7. Helgason CD, Antonchuk J, Bodner C, et al. Homeostasis and regeneration of the hematopoietic stem cell pool is altered in SHIP-deficient mice. Blood 2003; 102: 3541-3547.
8. Iyer S, Viernes DR, Chisholm JD, et al. SHIP1 regulates MSC numbers and their osteolineage commitment by limiting induction of the PI3K/Akt/beta-Catenin/Id2 axis. Stem Cells Dev 2014; 23: 2336-2351.
9. Iyer S, Margulies BS, Kerr WG,. Role of SHIP1 in bone biology. Ann N Y Acad Sci 2013; 1280: 11-14.
10. Helgason CD, Damen JE, Rosten P, et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 1998; 12: 1610-1620.
11. Ghansah T, Paraiso KH, Highfill S, et al. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J Immunol 2004; 173: 7324-7330.
12. Kerr WG, Park MY, Maubert M, et al. SHIP deficiency causes Crohn's disease-like ileitis. Gut 2011; 60: 177-188.
13. Brooks R, Fuhler GM, Iyer S, et al. SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J Immunol 2010; 184: 3582-3589.
14. Fuhler GM, Brooks R, Toms B, et al. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol Med 2012; 18: 65-75.
15. Harrison DE, Jordan CT, Zhong RK, et al. Primitive hemopoietic stem cells: Direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol 1993; 21: 206-219.
16. Shojaei F, Wu X, Zhong C, et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007; 450: 825-831.
17. Osawa M, Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273: 242-245.
18. Jordan CT, Astle CM, Zawadzki J, et al. Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation. Exp Hematol 1995; 23: 1011-1015.
19. Beerman I, Bhattacharya D, Zandi S, et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 2010; 107: 5465-5470.
20. Muller-Sieburg CE, Cho RH, Karlsson L, et al. Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 2004; 103: 4111-4118.
21. Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
22. Zhou BO, Yue R, Murphy MM, et al. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 2014; 15: 154-168.
23. Pinho S, Lacombe J, Hanoun M, et al. PDGFRalpha and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med 2013; 210: 1351-1367.
24. Morikawa S, Mabuchi Y, Kubota Y, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009; 206: 2483-2496.
25. Wilson A, Laurenti E, Oser G, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008; 135: 1118-1129.
26. Morrison SJ, Wright DE, Weissman IL,. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA 1997; 94: 1908-1913.
27. Hunter MG, Avalos BR,. Phosphatidylinositol 3'-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol 1998; 160: 4979-4987.
28. Hunter MG, Jacob A, O'Donnell LC, et al. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia. J Immunol 2004; 173: 5036-5045.
29. Wang Y, Schulte BA, LaRue AC, et al. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 2006; 107: 358-366.
30. Viernes DR, Choi LB, Kerr WG, et al. Discovery and development of small molecule SHIP phosphatase modulators. Med Res Rev 2014; 34: 795-824.
31. Kerr WG,. Inhibitor and activator: Dual functions for SHIP in immunity and cancer. Ann N Y Acad Sci 2011; 1217: 1-17.
32. Geest CR, Coffer PJ,. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol 2009; 86: 237-250.
33. Tesio M, Oser GM, Baccelli I, et al. Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization. J Exp Med 2013; 210: 2337-2349.
34. Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441: 475-482.
35. Maxwell MJ, Srivastava N, Park MY, et al. SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammation. Genes Immun 2014; 15: 233-240.
36. Gibbs KD, Jr., Gilbert PM, Sachs K, et al. Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments. Blood 2011; 117: 4226-4233.
37. Link DC,. Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization. Semin Hematol 2000; 37: 25-32.
38. Hogge DE, Lansdorp PM, Reid D, et al. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 1996; 88: 3765-3773.
39. Molineux G, Pojda Z, Dexter TM,. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 1990; 75: 563-569.
40. O'Neill LA, Kaltschmidt C,. NF-κ B: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997; 20: 252-258.
41. Baldwin AS,. THE NF-κB AND IκB PROTEINS: New discoveries and insights. Annu Rev Immunol 1996; 14: 649-681.
42. Bar-Yehuda S, Madi L, Barak D, et al. Agonists to the A3 adenosine receptor induce G-CSF production via NF-κB activation. Exp Hematol 2002; 30: 1390-1398.
43. Conde C, Rambout X, Lebrun M, et al. The inositol phosphatase SHIP-1 inhibits NOD2-induced NF-κB activation by disturbing the interaction of XIAP with RIP2. PLoS One 2012; 7: e41005.
44. Li W, Wang H, Kuang CY, et al. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 2012; 363: 135-145.
45. Fujita T, Azuma Y, Fukuyama R, et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 2004; 166: 85-95.
46. Lieschke GJ, Burgess AW,. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N Engl J Med 1992; 327: 99-106.
47. Taichman RS, Emerson SG,. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 1994; 179: 1677-1682.
48. Taichman RS, Reilly MJ, Emerson SG,. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 1996; 87: 518-524.
49. Nioche S, Tazi A, Lecossier D, et al. Production of granulocyte colony-stimulating factor (G-CSF) by human cells: T lymphocyte-dependent and T lymphocyte-independent release of G-CSF by blood monocytes. Eur J Immunol 1988; 18: 1021-1026.
50. Luyendyk JP, Schabbauer GA, Tencati M, et al. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J Immunol 2008; 180: 4218-4226.
51. Fukuda K,. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs 2001; 25: 187-193.
52. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-98.
53. Tu Z, Ninos JM, Ma Z, et al. Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein. Blood 2001; 98: 2028-2038.
54. Bai L, Rohrschneider LR,. s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev 2010; 24: 1882-1892.